Skip to main content

Table 2 Evaluated outcomes by group from the study My body, My Rhythm, My Voice

From: “My Body, My Rhythm, My Voice”: a community dance pilot intervention engaging breast cancer survivors in physical activity in a middle-income country

Variables

Intervention group

Change Score

Control group

Change Score

 Adjust effectb

 

Baselinea

Post-interventiona

Baselinea

Post-interventiona

Mean

SD

Mean

SD

Post.-Bas.

Mean

SD

Mean

SD

Post.-Bas.

Coefficient

Confidence Interval 95%

Physical activity (accelerometry)

 Average sedentary time per week (hours per day)

12.53

4.01

12.51

4.50

0.26

10.58

3.90

10.39

3.77

−0.19

0.05

−1.02

1.13

 Average time of MVPA per week (minutes per day)

24.19

16.25

33.18

21.17

0.24

33.46

19.97

29.74

17.73

−3.71

13.01

3.33

22.69

Self-regulation in physical activity (BREQ-3)

    

0.31

        

 Intrinsic regulation

3.39

0.98

3.84

0.22

0.21

3.79

0.44

3.74

0.36

−0.05

0.50

0.11

0.89

 Integrated regulation

3.38

0.94

3.64

0.51

−0.39

3.69

0.45

3.62

0.60

−0.07

0.33

−0.06

0.71

 Identified regulation

3.65

0.64

3.89

0.27

0.26

3.85

0.29

3.82

0.37

−0.03

0.27

0.02

0.53

 Introjected regulation

1.06

0.97

1.37

0.93

0.24

0.96

0.79

1.16

1.05

0.21

0.10

−0.42

0.63

 External regulation

0.46

0.62

0.67

0.96

0.31

0.30

0.46

0.60

0.68

0.30

−0.09

−0.46

0.27

 Amotivation

0.86

0.96

0.47

0.52

0.21

0.43

0.60

0.37

0.54

−0.06

−0.33

−0.72

0.06

Quality of life (EORTC QLQ-C30)

 Global quality of life functioning

82.00

16.26

81.67

16.32

−0.33

81.61

19.21

84.77

17.26

3.16

−3.49

−10.97

3.98

 Physical functioning

86.40

10.27

89.07

10.34

2.67

94.71

6.01

92.18

7.98

−2.53

5.20

1.45

8.94

 Role functioning

92.00

14.53

91.33

17.43

−0.67

94.83

10.06

95.98

11.49

1.5

−1.82

−9.76

6.12

 Emotional functioning

76.33

19.94

77.67

22.27

1.33

84.20

12.27

81.32

16.91

−2.87

4.21

−3.07

11.48

 Cognitive functioning

83,33

20,97

85.33

14.69

2.00

89.66

11.28

87.93

14.01

−1.72

3.72

−4.52

11.97

 Social functioning

89.33

21.98

88.67

22.42

−0.67

92.53

14.49

92.53

12.27

0.00

−0.67

−13.40

12.07

 Fatigue

21.78

16.19

18.67

17.49

−3.11

13.03

16.55

15.33

14.97

2.30

−5.41

−13.14

2.32

 Nausea and vomiting

3.33

8.33

4.67

9.03

1.33

1.15

6.19

1.15

4.30

0.00

1.33

−3.65

6.32

 Pain

22.67

19.77

22.67

19.77

0.00

12.64

23.42

12.64

23.42

0.00

0.00

Non estimable

 

 Dyspnea

4.00

11.06

4.00

11.06

0.00

1.15

6.19

1.15

6.19

0.00

0.00

Non estimable

 

 Insomnia

24.00

26.39

12.00

18.95

−12.00

17.24

21.12

20.69

24.26

3.45

−15.45

−27.00

−3.89

 Appetite loss

6.67

13.61

13.33

19.25

667

1.15

6.19

2.30

8.60

1.15

5.52

−2.04

13.07

 Constipation

6.67

19.25

8.00

14.53

1.33

10.34

18.05

5.75

12.81

-4.60

5.93

−3.20

15.06

 Diarrhea

8.00

17.43

1.33

6.67

−6.67

4.60

14.70

8.05

19.22

3.45

−10.11

−20.65

0.42

 Financial difficulties

22.67

31.51

13.33

21.52

−9.33

13.79

24.43

8.05

19.22

−5.75

−3.59

−15.83

8.66

 Arm

21.33

20.01

19.11

20.16

−2.22

13.03

17.33

12.64

16.99

−0.38

−1.84

−12.72

9.05

 Breast

14.67

18.98

16.67

21.38

2.00

17.82

19.76

12.93

12.32

−4.89

6.89

−3.97

17.74

  1. Values are presented as mean and standard deviation, or number and percentage
  2. MVPA moderate to vigorous physical activity
  3. aData based on study participants completing both baseline and the 8-week follow-up
  4. bBased on a GEE analysis: Yij = β0 + β1 × group + β2 × time + β3 × (group × time)